AI Science Tracker
EN

Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study

Affiliation not stated in the reviewed material · 27 May 2022 · medicine

Discovery

Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study

Source check: Source checked. Not independent scientific confirmation.

Finding: A stacked deep/machine-learning ensemble predicts EGFR and ALK status against molecular reference in a consecutive test cohort; single-center design and reported test accuracy delimit generalization. Methods/Results: 1,089 retrospective training cases and 1,464 consecutive test cases; stacked ensemble of one DL and five ML models; test AUC .883 EGFR and .921 ALK, plus common/uncommon EGFR accuracy .83. Publisher article details and testing results checked.

Technology: 1,089 retrospective training cases and 1,464 consecutive test cases; stacked ensemble of one DL and five ML models; test AUC .883 EGFR and .921 ALK, plus common/uncommon EGFR accuracy .83. Publisher article details and testing results checked.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
1,089 retrospective training cases and 1,464 consecutive test cases; stacked ensemble of one DL and five ML models; test AUC .883 EGFR and .921 ALK, plus common/uncommon EGFR accuracy .83. Publisher article details and testing results checked.
Test and result
1,089 retrospective training cases and 1,464 consecutive test cases; stacked ensemble of one DL and five ML models; test AUC .883 EGFR and .921 ALK, plus common/uncommon EGFR accuracy .83. Publisher article details and testing results checked.
Limitation / still unknown
Methods/Results: 1,089 retrospective training cases and 1,464 consecutive test cases; stacked ensemble of one DL and five ML models; test AUC .883 EGFR and .921 ALK, plus common/uncommon EGFR accuracy .83. Publisher article details and testing results checked. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12931-022-02053-2

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.